IMCC - War In Gaza Forces Israel To Delay Medical Cannabis Reform | Benzinga
The Israel Ministry of Health announced the anticipated reform of medical cannabis regulations in the country in August, which was expected to come into effect on Dec. 29, 2023.
However, due to the Israel-Hamas war, the anticipated implementation of the medical cannabis regulatory reform has been postponed by three months, according to an update provided by cannabis company IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) on Friday.
The new regulations are expected to significantly reduce the restrictions imposed on the industry, allowing patients easier access to medical cannabis for their treatment. Furthermore, this reform has the potential to boost the country's exports of medical cannabis, benefitting both patients and the economy.
Oren Shuster, CEO of IMC, a cannabis company with operations in Israel and Germany, which was the first Israeli cannabis company to debut on the NASDAQ Capital Market in 2021, remains optimistic despite the delay.
"As ...